News

...

Mr. Lundstrom has established global business leadership in transgenic animals for discovery of human therapeutic antibodies with Ligand Pharmaceuticals Inc.

Dr. Lang brings extensive background knowledge in the therapeutic antibody sector including corporate strategy, R&D innovation, sales and business development.

AgonOx specializes in identifying and developing immuno-oncology therapeutics.

IPA has designed an advanced discovery platform for bispecific antibodies with validated binding attributes

Revenue ImmunoPrecise achieved record annual revenue of $10,926,268 in fiscal 2019.